-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Creatinine are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Creatinine.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ, AASK Study Investigators, CRIC Study Investigators
(2013) N Engl J Med 369: 2183-96 - The effect of aprotinin on outcome after coronary-artery bypass grafting.
Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF
(2008) N Engl J Med 358: 784-93 - Intensive blood-pressure control in hypertensive chronic kidney disease.
Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, AASK Collaborative Research Group
(2010) N Engl J Med 363: 918-29 - High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ
(2016) JAMA 315: 877-88 - Assessing Toxicity of Intravenous Crystalloids in Critically Ill Patients.
Kellum JA, Shaw AD
(2015) JAMA 314: 1695-7 - Multimarker approach for the prediction of heart failure incidence in the community.
Velagaleti RS, Gona P, Larson MG, Wang TJ, Levy D, Benjamin EJ, Selhub J, Jacques PF, Meigs JB, Tofler GH, Vasan RS
(2010) Circulation 122: 1700-6 - Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.
Pikula A, Beiser AS, DeCarli C, Himali JJ, Debette S, Au R, Selhub J, Toffler GH, Wang TJ, Meigs JB, Kelly-Hayes M, Kase CS, Wolf PA, Vasan RS, Seshadri S
(2012) Circulation 125: 2100-7 - Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS
(2005) Circulation 112: 969-75 - Estimated rate of prostacyclin secretion into the circulation of normal man.
FitzGerald GA, Brash AR, Falardeau P, Oates JA
(1981) J Clin Invest 68: 1272-6 - Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats.
Ohnishi A, Branch RA, Jackson K, Hamilton R, Biaggioni I, Deray G, Jackson EK
(1986) J Clin Invest 78: 1045-50 - Intervention with epinephrine in hypotension associated with mastocytosis.
Turk J, Oates JA, Roberts LJ
(1983) J Allergy Clin Immunol 71: 189-92 - Acute Kidney Injury as a Risk Factor for Delirium and Coma during Critical Illness.
Siew ED, Fissell WH, Tripp CM, Blume JD, Wilson MD, Clark AJ, Vincz AJ, Ely EW, Pandharipande PP, Girard TD
(2017) Am J Respir Crit Care Med 195: 1597-1607 - Metabolic Effects of Diet and Exercise in Patients with Moderate to Severe CKD: A Randomized Clinical Trial.
Ikizler TA, Robinson-Cohen C, Ellis C, Headley SAE, Tuttle K, Wood RJ, Evans EE, Milch CM, Moody KA, Germain M, Limkunakul C, Bian A, Stewart TG, Himmelfarb J
(2018) J Am Soc Nephrol 29: 250-259 - Biological markers of acute kidney injury.
Siew ED, Ware LB, Ikizler TA
(2011) J Am Soc Nephrol 22: 810-20 - Classifying AKI by Urine Output versus Serum Creatinine Level.
Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G
(2015) J Am Soc Nephrol 26: 2231-8 - Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction.
Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V
(2006) J Am Soc Nephrol 17: 433-41 - A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
Lewis J, Greene T, Appel L, Contreras G, Douglas J, Lash J, Toto R, Van Lente F, Wang X, Wright JT, AASK Study Group
(2004) J Am Soc Nephrol 15: 3175-83 - A multi-marker approach to predict incident CKD and microalbuminuria.
Fox CS, Gona P, Larson MG, Selhub J, Tofler G, Hwang SJ, Meigs JB, Levy D, Wang TJ, Jacques PF, Benjamin EJ, Vasan RS
(2010) J Am Soc Nephrol 21: 2143-9 - Pyridorin in type 2 diabetic nephropathy.
Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB, Collaborative Study Group
(2012) J Am Soc Nephrol 23: 131-6 - Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL, Seneff MG, Chawla LS
(2015) J Am Soc Nephrol 26: 2023-31 - Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma.
Kitching AR, Turner AL, Semple T, Li M, Edgtton KL, Wilson GR, Timoshanko JR, Hudson BG, Holdsworth SR
(2004) J Am Soc Nephrol 15: 1764-74 - Spontaneous dietary protein intake during progression of chronic renal failure.
Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM
(1995) J Am Soc Nephrol 6: 1386-91 - Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1.
Ma LJ, Nakamura S, Whitsitt JS, Marcantoni C, Davidson JM, Fogo AB
(2000) Kidney Int 58: 2425-36 - Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB
(2000) Kidney Int 58: 1219-27 - Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury.
Chen J, Chen JK, Harris RC
(2012) Kidney Int 82: 45-52 - Role for "uremic toxin" in the progressive loss of intact nephrons in chronic renal failure.
Motojima M, Nishijima F, Ikoma M, Kawamura T, Yoshioka T, Fogo AB, Sakai T, Ichikawa I
(1991) Kidney Int 40: 461-9 - Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.
Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB, Ikizler TA, Siew ED
(2015) Kidney Int 87: 640-8 - Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA
(1991) Kidney Int 40: 1020-31 - Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies.
Marx MA, Shuler CL, Tattersall JE, Golper TA
(1995) Kidney Int 48: 1994-7 - Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury.
Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, Go AS, Parikh CR, Peterson JF
(2010) Kidney Int 77: 536-42 - Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
Ma LJ, Jha S, Ling H, Pozzi A, Ledbetter S, Fogo AB
(2004) Kidney Int 65: 106-15 - Effect of salt supplementation on amphotericin B nephrotoxicity.
Llanos A, Cieza J, Bernardo J, Echevarria J, Biaggioni I, Sabra R, Branch RA
(1991) Kidney Int 40: 302-8 - Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans.
Hakim RM, Goldszer RC, Brenner BM
(1984) Kidney Int 25: 930-6 - Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.
O'Byrne S, Forte P, Roberts LJ, Morrow JD, Johnston A, Anggård E, Leslie RD, Benjamin N
(2000) Diabetes 49: 857-62 - A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.
Atkins MB, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Plasse T
(2001) Clin Cancer Res 7: 486-92 - Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.
Margolin K, Atkins M, Sparano J, Sosman J, Weiss G, Lotze M, Doroshow J, Mier J, O'Boyle K, Fisher R, Campbell E, Rubin J, Federighi D, Bursten S
(1997) Clin Cancer Res 3: 565-72 - Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy.
Persson F, Lewis JB, Lewis EJ, Rossing P, Hollenberg NK, Parving HH, AVOID Study Investigators
(2010) Diabetes Care 33: 2304-9 - FGF23 Concentration and Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes.
Chan GC, Divers J, Russell GB, Langefeld CD, Wagenknecht LE, Hsu FC, Xu J, Smith SC, Palmer ND, Hicks PJ, Bowden DW, Register TC, Ma L, Carr JJ, Freedman BI
(2018) Diabetes Care 41: 178-186 - Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE
(1998) Hypertension 32: 965-71 - Caffeine attenuates the renal vascular response to angiotensin II infusion.
Brown NJ, Ryder D, Nadeau J
(1993) Hypertension 22: 847-52
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
